Clinical trials
Scleroderma, Systemic trials in France with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2014 | 2 |
| 2015 | 2 |
| 2018 | 5 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 6 |
| 2022 | 4 |
| 2024 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Recruiting | 5 |
| Not yet recruiting | 2 |
| Unknown status | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 4 |
| Assistance Publique Hopitaux De Marseille | 4 |
| Poitiers University Hospital | 4 |
| University Hospital, Strasbourg, France | 4 |
| University Hospital, Bordeaux | 3 |
| University Hospital, Grenoble | 3 |
| University Hospital, Lille | 3 |
| Hospices Civils de Lyon | 2 |
| University Hospital, Montpellier | 2 |
| CHU de Reims | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Scleroderma, Systemic | 34 |
| Scleroderma, Diffuse | 7 |
| Autoimmune Diseases | 3 |
| Connective Tissue Diseases | 3 |
| Lupus Erythematosus, Systemic | 3 |
| Myositis | 2 |
| Sjogren's Syndrome | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Angioedema | 1 |
| Arthritis, Psoriatic | 1 |
Trials
Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.